Skip to contentN
Nutra Pharma Corp
N
NPHCNutra Pharma Corp Q3 2017 · 10-Q
Revenue$38.05K$38.05K−46.0% vs Q3 2016 Net Income-$981.45K-$981.45KN/M vs Q3 2016 EPS Diluted$0.00$0.00— vs Q3 2016 Gross Profit$33,709−44.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Nutra Pharma Corp · CIK 1119643 · Engraved from SEC EDGAR
Operating Cash Flowderived-$244,704N/M Margins · derivedGross margin88.6%+2.7 pt vs Q3 2016
Operating margin-718.9%−1.0 pt vs Q3 2016
Net margin-2579.4%−1665.8 pt vs Q3 2016
ended Sep 30, 2017 · filed Nov 20, 2017 · 51 d after period end